Smith Graham & Co Investment Advisors’s Patterson-UTI PTEN Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.68M	Sell	340,959 -34,946	-9%	-$425K	0.42%	116
2023 Q3	$5.2M	Buy	+375,905	New	+$5.5M	0.65%	67
2015 Q2	–	Sell	-127,530	Closed	-$2.39M	–	138
2015 Q1	$2.39M	Buy	127,530 +24,330	+24%	+$417K	0.32%	129
2014 Q4	$1.71M	Buy	103,200 +23,180	+29%	+$489K	0.24%	133
2014 Q3	$2.6M	Buy	80,020 +4,770	+6%	+$162K	0.38%	117
2014 Q2	$2.63M	Sell	75,250 -810	-1%	-$26.6K	0.37%	112
2014 Q1	$2.41M	Sell	76,060 -1,140	-1%	-$31.7K	0.35%	114
2013 Q4	$1.96M	Sell	77,200 -28,310	-27%	-$678K	0.28%	128
2013 Q3	$2.26M	Sell	105,510 -1,280	-1%	-$26.3K	0.33%	129
2013 Q2	$2.07M	Buy	+106,790	New	+$2.33M	0.32%	127

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Smith Graham & Co Investment Advisors's PTEN Position: Q4 2023 in Review

Smith Graham & Co Investment Advisors reduced its Patterson-UTI (PTEN) stake by 9.3% in Q4 2023, selling an estimated $425K and leaving 340,959 shares worth $3.68M. The position accounts for 0.42% of the portfolio, ranked #116.

Smith Graham & Co Investment Advisors first reported a position in PTEN in Q2 2013 and has held it in 10 quarters since. The position peaked at $5.2M in Q3 2023. 359 funds tracked by Wall St. Rank hold PTEN as of Q4 2023.

Smith Graham & Co Investment Advisors held 340,959 shares of Patterson-UTI worth $3.68M as of Q4 2023.
Smith Graham & Co Investment Advisors sold 34,946 Patterson-UTI shares in Q4 2023, an estimated $425K.
Patterson-UTI made up 0.42% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #116 holding.
Smith Graham & Co Investment Advisors first reported a position in Patterson-UTI in Q2 2013 and has held it in 10 quarters since.
Smith Graham & Co Investment Advisors's Patterson-UTI position peaked at $5.2M in Q3 2023.
359 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2023.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.